SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-005397
Filing Date
2020-05-06
Accepted
2020-05-06 16:02:32
Documents
77
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vvus-20200331x10q.htm 10-Q 1991308
2 EX-31.1 vvus-20200331ex311eecea2.htm EX-31.1 19939
3 EX-31.2 vvus-20200331ex312a703e8.htm EX-31.2 19577
4 EX-32 vvus-20200331xex32.htm EX-32 16828
  Complete submission text file 0001558370-20-005397.txt   7308787

Data Files

Seq Description Document Type Size
5 EX-101.INS vvus-20200331.xml EX-101.INS 1508870
6 EX-101.SCH vvus-20200331.xsd EX-101.SCH 48531
7 EX-101.CAL vvus-20200331_cal.xml EX-101.CAL 67013
8 EX-101.DEF vvus-20200331_def.xml EX-101.DEF 196435
9 EX-101.LAB vvus-20200331_lab.xml EX-101.LAB 428465
10 EX-101.PRE vvus-20200331_pre.xml EX-101.PRE 371513
Mailing Address 900 E. HAMILTON AVENUE SUITE 550 CAMPBELL CA 95008
Business Address 900 E. HAMILTON AVENUE SUITE 550 CAMPBELL CA 95008 6509345200
VIVUS INC (Filer) CIK: 0000881524 (see all company filings)

IRS No.: 943136179 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33389 | Film No.: 20852535
SIC: 2834 Pharmaceutical Preparations